HopeStage
Back to all studies
CompletedNCT00423878

Antipsychotic medicines and metabolic health in schizophrenia

About this titleRead the official source — NCT00423878
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Colton and 27 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2007
Recruitment status
Completed
Enrollment listed in the registry
215
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00423878
Official title
Show the full official title

Clinical Management of Metabolic Problems in Patients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Colton · Palo Alto · New Haven

25 more locations
  • Boca Raton
  • Miami
  • Atlanta
  • Augusta
  • Iowa City
  • Wichita
  • Shreveport
  • Glen Burnie
  • Boston
  • Fall River
  • Worcester
  • Detroit
  • Minneapolis
  • St Louis
  • Albuquerque
  • New York
  • Rochester
  • Butner
  • Chapel Hill
  • Charlotte
  • Cincinnati
  • Philadelphia
  • Dallas
  • Houston
  • San Antonio

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Risperidone, Olanzapine, Quetiapine and Aripiprazole.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies